+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Progestrone Market by Type (Natural Progesterone, Synthetic Progesterone), Mode of Delivery (Injectable, Oral, Suspended Form), Application - Forecast 2023-2030

  • PDF Icon

    Report

  • 194 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5532953
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Progestrone Market size was estimated at USD 1.15 billion in 2022, USD 1.30 billion in 2023, growing at a CAGR of 13.32% to reach USD 3.14 billion by 2030.

Market Segmentation & Coverage:

This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the Progestrone Market.
  • Based on Type, the market is studied across Natural Progesterone and Synthetic Progesterone. The Natural Progesterone is projected to witness significant market share during forecast period.
  • Based on Mode of Delivery, the market is studied across Injectable, Oral, and Suspended Form. The Injectable is projected to witness significant market share during forecast period.
  • Based on Application, the market is studied across Contraception, Dysfunctional Uterine Bleeding, Endometrial Cancer, Hyperplastic Precursor Lesions, and Regulation of the Menstrual Cycle. The Regulation of the Menstrual Cycle is projected to witness significant market share during forecast period.
  • Based on Region, the market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. Europe, Middle East & Africa is is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.74% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is an indispensable tool for assessing the Progestrone Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.

Market Share Analysis:

The Market Share Analysis offers invaluable insights into the vendor landscape Progestrone Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.

Key Company Profiles:

The report delves into recent significant developments in the Progestrone Market, highlighting leading vendors and their innovative profiles. These include Alkem Laboratories Ltd., Aquatic Remedies Pvt. Ltd, Bionpharma, Inc., Blubell Pharma Group Company, Cadila Pharmaceuticals, Caesar & Loretz Gmbh, Cipla Limited, Estrellas Life Sciences Private Limited, Fagron Industry, Glenmark Pharmaceuticals, Intas Pharmaceuticals Ltd., Lupin Limited, Shaanxi Hanjiang Pharmaceutical Group Co., Ltd., Shandong Octagon Chemicals Limited, Shanghai Yijing Industrial Co., Ltd., Sigmak Life Sciences, Sofgen Pharmaceuticals Llc, Teva Pharmaceuticals Industries Ltd., Virtus Pharmaceuticals Llc, and Wuhan Honor Bio-Pharm Co., Ltd.

The report offers valuable insights on the following aspects:

  1. Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.
  2. Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.
  3. Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.
  4. Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.
  5. Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast for the Progestrone Market?
  2. Which products, segments, applications, and areas hold the highest investment potential in the Progestrone Market?
  3. What is the competitive strategic window for identifying opportunities in the Progestrone Market?
  4. What are the latest technology trends and regulatory frameworks in the Progestrone Market?
  5. What is the market share of the leading vendors in the Progestrone Market?
  6. Which modes and strategic moves are suitable for entering the Progestrone Market?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Progestrone Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of amenorrhea, breast cancer, and AIDS
5.1.1.2. Growing female infertility rates all over the globe
5.1.1.3. Increasing demand owing to different gynecological treatment
5.1.2. Restraints
5.1.2.1. Concern associated with side effects of progesterone and progestin
5.1.3. Opportunities
5.1.3.1. Technological advancements in the medical field
5.1.3.2. Ongoing research and development activities
5.1.4. Challenges
5.1.4.1. Lack of awareness about hormone therapy
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of COVID-19
5.5. Cumulative Impact of Russia-Ukraine Conflict
5.6. Cumulative Impact of High Inflation
5.7. Porter’s Five Forces Analysis
5.7.1. Threat of New Entrants
5.7.2. Threat of Substitutes
5.7.3. Bargaining Power of Customers
5.7.4. Bargaining Power of Suppliers
5.7.5. Industry Rivalry
5.8. Value Chain & Critical Path Analysis
5.9. Regulatory Framework
5.10. Client Customization
6. Progestrone Market, by Type
6.1. Introduction
6.2. Natural Progesterone
6.3. Synthetic Progesterone
7. Progestrone Market, by Mode of Delivery
7.1. Introduction
7.2. Injectable
7.3. Oral
7.4. Suspended Form
8. Progestrone Market, by Application
8.1. Introduction
8.2. Contraception
8.3. Dysfunctional Uterine Bleeding
8.4. Endometrial Cancer
8.5. Hyperplastic Precursor Lesions
8.6. Regulation of the Menstrual Cycle
9. Americas Progestrone Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Progestrone Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Progestrone Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. Alkem Laboratories Ltd.
13.1.2. Aquatic Remedies Pvt. Ltd
13.1.3. Bionpharma, Inc.
13.1.4. Blubell Pharma Group Company
13.1.5. Cadila Pharmaceuticals
13.1.6. Caesar & Loretz Gmbh
13.1.7. Cipla Limited
13.1.8. Estrellas Life Sciences Private Limited
13.1.9. Fagron Industry
13.1.10. Glenmark Pharmaceuticals
13.1.11. Intas Pharmaceuticals Ltd.
13.1.12. Lupin Limited
13.1.13. Shaanxi Hanjiang Pharmaceutical Group Co., Ltd.
13.1.14. Shandong Octagon Chemicals Limited
13.1.15. Shanghai Yijing Industrial Co., Ltd.
13.1.16. Sigmak Life Sciences
13.1.17. Sofgen Pharmaceuticals Llc
13.1.18. Teva Pharmaceuticals Industries Ltd.
13.1.19. Virtus Pharmaceuticals Llc
13.1.20. Wuhan Honor Bio-Pharm Co., Ltd.
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. PROGESTRONE MARKET RESEARCH PROCESS
FIGURE 2. PROGESTRONE MARKET SIZE, 2022 VS 2030
FIGURE 3. PROGESTRONE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. PROGESTRONE MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. PROGESTRONE MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. PROGESTRONE MARKET DYNAMICS
FIGURE 7. PROGESTRONE MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
FIGURE 8. PROGESTRONE MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 9. PROGESTRONE MARKET SIZE, BY MODE OF DELIVERY, 2022 VS 2030 (%)
FIGURE 10. PROGESTRONE MARKET SIZE, BY MODE OF DELIVERY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. PROGESTRONE MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
FIGURE 12. PROGESTRONE MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS PROGESTRONE MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 14. AMERICAS PROGESTRONE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES PROGESTRONE MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 16. UNITED STATES PROGESTRONE MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC PROGESTRONE MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC PROGESTRONE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PROGESTRONE MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PROGESTRONE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 21. PROGESTRONE MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 22. PROGESTRONE MARKET SHARE, BY KEY PLAYER, 2022
List of Tables
TABLE 1. PROGESTRONE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. PROGESTRONE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL PROGESTRONE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. PROGESTRONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 6. PROGESTRONE MARKET SIZE, BY NATURAL PROGESTERONE, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. PROGESTRONE MARKET SIZE, BY SYNTHETIC PROGESTERONE, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. PROGESTRONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 9. PROGESTRONE MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. PROGESTRONE MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. PROGESTRONE MARKET SIZE, BY SUSPENDED FORM, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. PROGESTRONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 13. PROGESTRONE MARKET SIZE, BY CONTRACEPTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. PROGESTRONE MARKET SIZE, BY DYSFUNCTIONAL UTERINE BLEEDING, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. PROGESTRONE MARKET SIZE, BY ENDOMETRIAL CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. PROGESTRONE MARKET SIZE, BY HYPERPLASTIC PRECURSOR LESIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. PROGESTRONE MARKET SIZE, BY REGULATION OF THE MENSTRUAL CYCLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. AMERICAS PROGESTRONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 19. AMERICAS PROGESTRONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS PROGESTRONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS PROGESTRONE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 22. ARGENTINA PROGESTRONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 23. ARGENTINA PROGESTRONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 24. ARGENTINA PROGESTRONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 25. BRAZIL PROGESTRONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 26. BRAZIL PROGESTRONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 27. BRAZIL PROGESTRONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 28. CANADA PROGESTRONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 29. CANADA PROGESTRONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 30. CANADA PROGESTRONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 31. MEXICO PROGESTRONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 32. MEXICO PROGESTRONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 33. MEXICO PROGESTRONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES PROGESTRONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES PROGESTRONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES PROGESTRONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES PROGESTRONE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 38. ASIA-PACIFIC PROGESTRONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 39. ASIA-PACIFIC PROGESTRONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 40. ASIA-PACIFIC PROGESTRONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 41. ASIA-PACIFIC PROGESTRONE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 42. AUSTRALIA PROGESTRONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 43. AUSTRALIA PROGESTRONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 44. AUSTRALIA PROGESTRONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 45. CHINA PROGESTRONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 46. CHINA PROGESTRONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 47. CHINA PROGESTRONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 48. INDIA PROGESTRONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 49. INDIA PROGESTRONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 50. INDIA PROGESTRONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 51. INDONESIA PROGESTRONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 52. INDONESIA PROGESTRONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 53. INDONESIA PROGESTRONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 54. JAPAN PROGESTRONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 55. JAPAN PROGESTRONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 56. JAPAN PROGESTRONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 57. MALAYSIA PROGESTRONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 58. MALAYSIA PROGESTRONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 59. MALAYSIA PROGESTRONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 60. PHILIPPINES PROGESTRONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 61. PHILIPPINES PROGESTRONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 62. PHILIPPINES PROGESTRONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 63. SINGAPORE PROGESTRONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 64. SINGAPORE PROGESTRONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 65. SINGAPORE PROGESTRONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 66. SOUTH KOREA PROGESTRONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 67. SOUTH KOREA PROGESTRONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 68. SOUTH KOREA PROGESTRONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 69. TAIWAN PROGESTRONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 70. TAIWAN PROGESTRONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 71. TAIWAN PROGESTRONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 72. THAILAND PROGESTRONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 73. THAILAND PROGESTRONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 74. THAILAND PROGESTRONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 75. VIETNAM PROGESTRONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 76. VIETNAM PROGESTRONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 77. VIETNAM PROGESTRONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 78. EUROPE, MIDDLE EAST & AFRICA PROGESTRONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA PROGESTRONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA PROGESTRONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA PROGESTRONE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 82. DENMARK PROGESTRONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 83. DENMARK PROGESTRONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 84. DENMARK PROGESTRONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 85. EGYPT PROGESTRONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 86. EGYPT PROGESTRONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 87. EGYPT PROGESTRONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 88. FINLAND PROGESTRONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 89. FINLAND PROGESTRONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 90. FINLAND PROGESTRONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 91. FRANCE PROGESTRONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 92. FRANCE PROGESTRONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 93. FRANCE PROGESTRONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 94. GERMANY PROGESTRONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 95. GERMANY PROGESTRONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 96. GERMANY PROGESTRONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 97. ISRAEL PROGESTRONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 98. ISRAEL PROGESTRONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 99. ISRAEL PROGESTRONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 100. ITALY PROGESTRONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 101. ITALY PROGESTRONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 102. ITALY PROGESTRONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 103. NETHERLANDS PROGESTRONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 104. NETHERLANDS PROGESTRONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 105. NETHERLANDS PROGESTRONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 106. NIGERIA PROGESTRONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 107. NIGERIA PROGESTRONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 108. NIGERIA PROGESTRONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 109. NORWAY PROGESTRONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 110. NORWAY PROGESTRONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 111. NORWAY PROGESTRONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 112. POLAND PROGESTRONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 113. POLAND PROGESTRONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 114. POLAND PROGESTRONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 115. QATAR PROGESTRONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 116. QATAR PROGESTRONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 117. QATAR PROGESTRONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 118. RUSSIA PROGESTRONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 119. RUSSIA PROGESTRONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 120. RUSSIA PROGESTRONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 121. SAUDI ARABIA PROGESTRONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 122. SAUDI ARABIA PROGESTRONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 123. SAUDI ARABIA PROGESTRONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 124. SOUTH AFRICA PROGESTRONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 125. SOUTH AFRICA PROGESTRONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 126. SOUTH AFRICA PROGESTRONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 127. SPAIN PROGESTRONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 128. SPAIN PROGESTRONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 129. SPAIN PROGESTRONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 130. SWEDEN PROGESTRONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 131. SWEDEN PROGESTRONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 132. SWEDEN PROGESTRONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 133. SWITZERLAND PROGESTRONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 134. SWITZERLAND PROGESTRONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 135. SWITZERLAND PROGESTRONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 136. TURKEY PROGESTRONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 137. TURKEY PROGESTRONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 138. TURKEY PROGESTRONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 139. UNITED ARAB EMIRATES PROGESTRONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 140. UNITED ARAB EMIRATES PROGESTRONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 141. UNITED ARAB EMIRATES PROGESTRONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 142. UNITED KINGDOM PROGESTRONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM PROGESTRONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 144. UNITED KINGDOM PROGESTRONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 145. PROGESTRONE MARKET, FPNV POSITIONING MATRIX, 2022
TABLE 146. PROGESTRONE MARKET SHARE, BY KEY PLAYER, 2022
TABLE 147. PROGESTRONE MARKET LICENSE & PRICING

Companies Mentioned

  • Alkem Laboratories Ltd.
  • Aquatic Remedies Pvt. Ltd
  • Bionpharma, Inc.
  • Blubell Pharma Group Company
  • Cadila Pharmaceuticals
  • Caesar & Loretz Gmbh
  • Cipla Limited
  • Estrellas Life Sciences Private Limited
  • Fagron Industry
  • Glenmark Pharmaceuticals
  • Intas Pharmaceuticals Ltd.
  • Lupin Limited
  • Shaanxi Hanjiang Pharmaceutical Group Co., Ltd.
  • Shandong Octagon Chemicals Limited
  • Shanghai Yijing Industrial Co., Ltd.
  • Sigmak Life Sciences
  • Sofgen Pharmaceuticals Llc
  • Teva Pharmaceuticals Industries Ltd.
  • Virtus Pharmaceuticals Llc
  • Wuhan Honor Bio-Pharm Co., Ltd.

Methodology

Loading
LOADING...

Table Information